Department of Psychology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, United States of America.
Seattle Division, VA Puget Sound Healthcare System, Seattle, Washington, United States of America.
PLoS One. 2023 May 12;18(5):e0285658. doi: 10.1371/journal.pone.0285658. eCollection 2023.
Research and clinical interest in self-compassion has grown due to its associations with physical and mental health benefits. Widely used measures of self-compassion have conceptual and psychometric limitations that warrant attention. The purpose of this project was to develop a new self-compassion measure, the Brief Self-Compassion Inventory (BSCI), and test its psychometric properties. We developed items for the BSCI based on theory, prior research, and expert and cancer patient feedback. The BSCI was then tested with adults diagnosed with breast, gastrointestinal, lung, or prostate cancer (N = 404). Confirmatory factor analysis suggested a unidimensional structure, and internal consistency reliability was excellent. Construct validity of the BSCI was established through its correlations with psychological variables hypothesized to be related to self-compassion, such as mindfulness, acceptance of cancer, and other coping strategies. Furthermore, measurement invariance testing of the BSCI indicated that it could be used across patients of varying genders, cancer types, and stages of illness. In conclusion, the 5-item BSCI was determined to be psychometrically sound and suitable for use with adults of varying genders, cancer types, and stages of disease. The measure warrants testing with other medical and nonclinical populations.
由于与身心健康益处的关联,自我同情的研究和临床兴趣不断增加。广泛使用的自我同情测量方法在概念和心理测量方面存在局限性,值得关注。本项目旨在开发一种新的自我同情测量工具,即简短自我同情量表(BSCI),并测试其心理测量特性。我们根据理论、先前的研究以及专家和癌症患者的反馈为 BSCI 开发了项目。然后,BSCI 在被诊断患有乳腺癌、胃肠道癌、肺癌或前列腺癌的成年人中进行了测试(N=404)。验证性因素分析表明存在单一维度结构,内部一致性信度极好。BSCI 的构念效度通过与假设与自我同情相关的心理变量(如正念、对癌症的接受和其他应对策略)的相关性来建立。此外,BSCI 的测量不变性测试表明,它可以在不同性别、癌症类型和疾病阶段的患者中使用。总之,5 项 BSCI 在心理测量上是可靠的,适用于不同性别、癌症类型和疾病阶段的成年人。该测量方法值得在其他医学和非临床人群中进行测试。